Want to see GB:FUM full AI Analyst Report?

Futura Medical (FUM) Earnings Dates, Call Summary & Reports

Q: What is the P/E ratio of Futura Medical PLC stock?

The P/E ratio of {name} is N/A.

55 Followers

Earnings Data

Report Date

Sep 22, 2026

TBA (Confirmed)

Period Ending

2026 (Q2)

Consensus EPS Forecast

―

Last Year’s EPS

-0.02

Same Quarter Last Year

Analyst Consensus

―

Based on 0 Analysts Ratings

Earnings Call Summary

Q2 2025

Earnings Call Date:Sep 30, 2025|

% Change Since:

Earnings Call Sentiment|Negative

The earnings call reflected significant financial and operational challenges with revenue shortfalls, unexpected market performance, and inventory issues. While there are promising R&D developments, these are long-term. Immediate financial pressures and market challenges dominate the current outlook.

Company Guidance

During the investor presentation call for Futura Medical plc, Interim CEO Alex Duggan provided guidance indicating that the company's full-year 2025 performance is expected to fall significantly below market expectations due to challenges in sustaining consumer uptake and lower-than-anticipated repeat sales. Despite launching in seven countries in H1, the initial strong trials did not translate into continued sales, affecting supply volumes and royalty streams. Angela Hildreth reported a revenue of just over GBP 1 million for the first half of 2025, with a gross profit of GBP 0.7 million, but also highlighted a GBP 0.49 million provision for inventory obsolescence. The company incurred an exceptional charge of GBP 3.6 million due to impairment of U.S. plant and equipment, contributing to a loss after tax of GBP 6.6 million. The adjusted loss after tax was GBP 1.9 million, with cash reserves at GBP 3.69 million at the period's end. Full-year sales for 2025 are now projected to be between GBP 1.3 million and GBP 1.4 million, with cash reserves reduced to GBP 2.7 million by the end of August. The company is actively exploring commercial and financing options to extend its cash runway, which currently runs into January 2026.

R&D Developments

Futura is advancing two new products: Project Intense and WSD4000. Project Intense aims to enhance sensorial effects for men, with regulatory approval expected by the end of 2025. WSD4000 targets women's sexual response, with significant market potential, though it is expected to launch in the latter half of 2028.

Cost Reductions

Core G&A costs were reduced from GBP 3.4 million to GBP 2.6 million, demonstrating successful cost management efforts.

Patent Advancements

Notable progress in patent coverage with expected notice of allowance in China and a continuation patent in the U.S. that should trigger a GBP 1.9 million milestone payment in 2026.

Futura Medical (GB:FUM) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

GB:FUM Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Sep 22, 2026	2026 (Q2)	- / -	-0.022	―	―	―
Apr 29, 2026	2025 (Q4)	- / >-0.01	0.001	-700.00% (>-0.01)	―	―
Sep 30, 2025	2025 (Q2)	- / -0.02	0.003	-833.33% (-0.02)	―	―
Apr 15, 2025	2024 (Q4)	- / <0.01	-0.016	106.25% (+0.02)	―	―
Sep 10, 2024	2024 (Q2)	- / <0.01	-0.006	150.00% (<+0.01)	―	―
Apr 10, 2024	2023 (Q4)	- / -0.02	-0.012	-33.33% (>-0.01)	―	―
Sep 18, 2023	2023 (Q2)	- / >-0.01	-0.009	33.33% (<+0.01)	―	―
Apr 05, 2023	2022 (Q4)	- / -0.01	-0.012	0.00% (0.00)	―	―
Sep 13, 2022	2022 (Q2)	- / >-0.01	-0.006	-50.00% (>-0.01)	―	―
Apr 26, 2022	2021 (Q4)	- / -0.01	-0.006	-100.00% (>-0.01)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

GB:FUM Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Apr 29, 2026	1.30 p	0.89 p	-31.54%
Sep 30, 2025	3.84 p	3.80 p	-1.04%
Apr 15, 2025	8.95 p	9.64 p	+7.71%
Sep 10, 2024	40.00 p	38.00 p	-5.00%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Futura Medical PLC (GB:FUM) report earnings?

Futura Medical PLC (GB:FUM) is schdueled to report earning on Sep 22, 2026, TBA (Confirmed).

What is Futura Medical PLC (GB:FUM) earnings time?

Futura Medical PLC (GB:FUM) earnings time is at Sep 22, 2026, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of Futura Medical PLC stock?

The P/E ratio of Futura Medical is N/A.

What is GB:FUM EPS forecast?

Currently, no data Available